408 related articles for article (PubMed ID: 25451903)
41. Comparing continuous subcutaneous insulin infusion and multiple daily injections in children with Type 1 diabetes in Sweden from 2011 to 2016-A longitudinal study from the Swedish National Quality Register (SWEDIABKIDS).
Fureman AL; Lilja M; Lind T; Särnblad S; Bladh M; Samuelsson U
Pediatr Diabetes; 2021 Aug; 22(5):766-775. PubMed ID: 33929074
[TBL] [Abstract][Full Text] [Related]
42. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
43. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
44. [Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].
Pańkowska E; Lipka M; Wysocka M; Szypowska A; Trippenbach-Dulska H; Czaplińska M; Kołodziejska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):11-5. PubMed ID: 12831632
[TBL] [Abstract][Full Text] [Related]
45. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
[TBL] [Abstract][Full Text] [Related]
46. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
Thabit H; Hovorka R
Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
[TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion?
Nuboer R; Bruining GJ
Pediatr Diabetes; 2006 Aug; 7 Suppl 4():39-44. PubMed ID: 16774617
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
[TBL] [Abstract][Full Text] [Related]
49. Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.
Fendler W; Baranowska AI; Mianowska B; Szadkowska A; Mlynarski W
Acta Diabetol; 2012 Oct; 49(5):363-70. PubMed ID: 21964866
[TBL] [Abstract][Full Text] [Related]
50. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
51. Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model.
Zöllner YF; Ziegler R; Stüve M; Krumreich J; Schauf M
J Diabetes Sci Technol; 2016 Sep; 10(5):1142-8. PubMed ID: 26902790
[TBL] [Abstract][Full Text] [Related]
52. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
Weintrob N; Shalitin S; Phillip M
Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study.
Moniotte S; Owen M; Barrea T; Robert A; Lysy PA
Pediatr Diabetes; 2017 Dec; 18(8):925-933. PubMed ID: 28251726
[TBL] [Abstract][Full Text] [Related]
54. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P
Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393
[TBL] [Abstract][Full Text] [Related]
55. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.
Ranasinghe PD; Maruthur NM; Nicholson WK; Yeh HC; Brown T; Suh Y; Wilson LM; Nannes EB; Berger Z; Bass EB; Golden SH
J Womens Health (Larchmt); 2015 Mar; 24(3):237-49. PubMed ID: 25713996
[TBL] [Abstract][Full Text] [Related]
56. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
Skogsberg L; Fors H; Hanas R; Chaplin JE; Lindman E; Skogsberg J
Pediatr Diabetes; 2008 Oct; 9(5):472-9. PubMed ID: 18721168
[TBL] [Abstract][Full Text] [Related]
57. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
[TBL] [Abstract][Full Text] [Related]
58. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
[TBL] [Abstract][Full Text] [Related]
59. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
60. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
